top of page
neurovision logo

LEYLA ANDERSON, MD, PHD, D(ABMLI)*

VP, BIOMARKER DEVELOPMENT

Dr. Anderson is a medical scientist with over 20 years of experience in the areas of infectious diseases, immunology and genomics. She completed her PhD in the disciplines of microbiology and immunology and pursued post-doctoral studies at Yale University and University of California, Davis. She is also board certified in Medial Laboratory Immunology to direct high-complexity diagnostic laboratories. Her area of expertise includes laboratory medicine, diagnostic testing, biomarker assay development, regulatory compliance, laboratory management, academic research and teaching including her tenure as a lecturer at University of Oxford, UK. Prior to joining NeuroVision, Dr. Anderson directed clinical trials operations at Quest Diagnostics Clinical Trails Lab in Valencia, including biomarker assay development, validation and implementation in Global Flow Cytometry, Molecular Biology and Anatomic Pathology departments in her capacity as an Associate Biomarker Director. She also acted as a testing site Principal Investigator for multiple companion diagnostics studies. Dr. Anderson is a recipient of two Alzheimer's Drug Discovery Foundation Diagnostic Accelerator Funding awards.

*Diplomate, American Board of Medical Laboratory Immunology (CLIA-approved)

bottom of page